Advertisement
Screener

Orchestra BioMed Holdings, Inc. (OBIO) Proceeds from Issuance of Debt

2.2 / 5 stars · 21/48 Roast Me

Orchestra BioMed Holdings, Inc. Proceeds from Issuance of Debt

Orchestra BioMed Holdings, Inc. (OBIO) reported Proceeds from Issuance of Debt of $15.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-12.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfDebt · last filed 2026-03-12

  • Orchestra BioMed Holdings, Inc. proceeds from issuance of debt for the quarter ending 2022-12-31 was $0.00.
  • Orchestra BioMed Holdings, Inc. proceeds from issuance of debt for the quarter ending 2022-09-30 was $0.00.
  • Orchestra BioMed Holdings, Inc. proceeds from issuance of debt for fiscal 2024 was $15.00M.
  • Orchestra BioMed Holdings, Inc. proceeds from issuance of debt for fiscal 2022 was $10.00M.
Period endProceeds from Issuance of Debt 3 monthProceeds from Issuance of Debt 6 monthProceeds from Issuance of Debt 9 monthProceeds from Issuance of Debt 12 month
2024-12-31$15.00M
10-K · filed 2026-03-12
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27
$0.00
derived: sum of 2 quarters · filed 2024-03-27
$10.00M
10-K · filed 2024-03-27
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$10.00M
10-Q · filed 2023-11-13
2022-06-30$10.00M
10-Q · filed 2023-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
Orthofix Medical Inc. (OFIX)$0.373B
Embecta Corp. (EMBC)United States$0.319B2.10
CARLSMED, INC. (CARL)United States$0.405B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71